NMPA Approval

Golimumab Injection

Approval Number

S20170050

Registration Date

December 17, 2019

Previous Approval Numbers

S20170050

Drug Information

Generic Name

戈利木单抗注射液

Trade Name

欣普尼

Brand Name

欣普尼

Dosage Form

注射剂

Strength

50mg/0.5ml/支

Drug Type

生物制品

Registration Date

December 17, 2019

Expiry Date

December 16, 2024

Company Address

Einsteinweg 101, 2333 CB Leiden, The Netherlands

Company NameCilag AG

Company Address

Hochstrasse 201, CH-8200 Schaffhausen, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

戈利木单抗注射液 - NMPA 批准文号 | MedPath